Advisory Committee on the Medical Uses of Isotopes; Call for Nominations, 5115-5116 [2019-02721]

Download as PDF 5115 Federal Register / Vol. 84, No. 34 / Wednesday, February 20, 2019 / Notices NON-CFO ACT AGENCIES—Continued Item 18 ....... 19 ....... 20 ....... 21 ....... 22 ....... 23 ....... 24 ....... 25 ....... 26 ....... 27 ....... 28 ....... 29 ....... 30 ....... 31 ....... 32 ....... Agency Holocaust Memorial Museum. International Trade Commission. Merit Systems Protection Board. National Archives and Records Administration. National Endowment for the Arts. National Endowment for the Humanities. National Labor Relations Board. National Transportation Safety Board. Office of Management and Budget. Office of Special Counsel .. Office of the United States Trade Representative. Peace Corps ...................... Railroad Retirement Board Securities and Exchange Commission. Selective Service System .. Point of contact Email Telephone Helen Shepherd ................. hshepherd@ushmm.org .... https://www.ushmm.org. Debra Bridge ...................... Debra.Bridge@usitc.gov .... 202–488–0400 x396 202–205–2004 Nancie Kebioh-Gray .......... 202–254–4513 www.mspb.gov. 301–837–2902 www.archives.gov. Ned Read ........................... nancie.kebioh-gray@ mspb.gov. kimberly.richardson@ nara.gov. readn@arts.gov ................. 202–682–5782 https://www.arts.gov. Robert Straughter .............. rstraughter@neh.gov ......... 202–606–8237 www.neh.gov. Marsha Porter .................... Marsha.Porter@nlrb.gov .... 202–273–3726 https://www.nlrb.gov. Sandra Lawson .................. Lisa Kleiner ........................ Sandra.lawson@nlrb.gov ... Lisa.Kleiner@ntsb.gov ....... 202–273–3908 202–314–6462 www.ntsb.gov. Nate Benjamin ................... 202–395–5159 www.whitehouse.gov. 202–804–7064 202–804–7063 202–395–9410 https://www.osc.gov/. Enrique Colon .................... Suzanne Hensell ................ Keith Earley ....................... Melissa Csigi ...................... nathaniel_h_benjamin@ omb.eop.gov. ekaybulkina@osc.gov ........ kkammann@osc.gov ......... Deborah_Tidwell@ ustr.eop.gov. ecolon@peacecorps.gov ... shensell@peacecorps.gov Keith.Earley@rrb.gov ......... csigim@sec.gov ................. 202–692–1238 202–692–1888 312–751–4990 202–551–7647 www.peacecorps.gov. Vernetta Fields ................... Kevin Adams ...................... Vernetta.fields@sss.gov .... Kevin.adams@sss.gov ...... 703–605–4040 703–605–4060 www.sss.gov. Kimberly Richardson .......... Elena Kaybulkina ............... Karl Kammann ................... Deborah Tidwell ................. ‘‘Estimated number of respondents’’ to read 20,800, and correct the ‘‘Estimated total annual burden hours’’ to read 1,733. [FR Doc. 2019–02720 Filed 2–19–19; 8:45 am] BILLING CODE 3110–01–P NATIONAL ARCHIVES AND RECORDS ADMINISTRATION [NARA–2019–014] [FR Doc. 2019–02812 Filed 2–19–19; 8:45 am] Agency Information Collection Activities: Submission for OMB Review; Comment Request; Correction National Archives and Records Administration (NARA). ACTION: Notice; correction. AGENCY: NARA published a document in the Federal Register on February 12, 2019, notifying the public that we have submitted to OMB a request to renew the information collections 3095–0037 (forms relating to civilian service records) and 3095–0060 (volunteer service application), and soliciting comments on them. The document contained incorrect numbers of respondents and annual hours for 3095– 0037. FOR FURTHER INFORMATION CONTACT: Tamee Fechhelm by phone at 301–837– 1694 or by fax at 301–837–0319. SUPPLEMENTARY INFORMATION: In the Federal Register of February 12, 2019 (84 FR 3502), on page 3502 near the top of the third column, correct the SUMMARY: VerDate Sep<11>2014 17:16 Feb 19, 2019 Swarnali Haldar, Executive for Information Services/CIO. Jkt 247001 BILLING CODE 7515–01–P Sunshine Act Meetings; Regular Board of Directors Meeting 12:00 p.m., Wednesday, December 19, 2018. PLACE: NeighborWorks America— Gramlich Boardroom, 999 North Capitol Street NE, Washington, DC 20002. STATUS: Open (with the exception of Executive Session). MATTERS TO BE CONSIDERED: The General Counsel of the Corporation has certified that in his opinion, one or more of the exemptions set forth in 5 U.S.C. 552 (b)(2) and (4) permit closure of the following portion(s) of this meeting: • Report from CEO • Internal Audit Report TIME AND DATE: Agenda I. Call to Order Frm 00070 Fmt 4703 www.usitc.gov. https://ustr.gov/. www.rrb.gov. www.sec.gov. II. Approval of Minutes III. Executive Session: Report from CEO IV. Action Item Client Management System (CMS) V. Action Item LIFT 6.0 VI. Discussion Item Delegation of Authority VII. Management Program Background and Updates VIII. Adjournment CONTACT PERSON FOR MORE INFORMATION: NEIGHBORHOOD REINVESTMENT CORPORATION PO 00000 Website Sfmt 4703 Rutledge Simmons, EVP & General Counsel/Secretary, (202) 760–4105; Rsimmons@nw.org. Rutledge Simmons, EVP & General Counsel/Corporate Secretary. [FR Doc. 2019–02980 Filed 2–15–19; 4:15 pm] BILLING CODE 7570–02–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes; Call for Nominations Nuclear Regulatory Commission. ACTION: Call for nominations. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is advertising for nominations for the Nuclear Medicine Physician position and the Patients’ Rights Advocate position on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nuclear SUMMARY: E:\FR\FM\20FEN1.SGM 20FEN1 5116 Federal Register / Vol. 84, No. 34 / Wednesday, February 20, 2019 / Notices Medicine Physician nominees should currently be practicing nuclear medicine in a clinical setting. Patients’ Rights Advocate nominees should have professional or personal experience with or knowledge about patient advocacy. Also, involvement or leadership with patient advocacy organizations is preferred. DATES: Nominations are due on or before April 22, 2019. NOMINATION PROCESS: Submit an electronic copy of resume or curriculum vitae, along with a cover letter, to Ms. Kellee Jamerson, Kellee.Jamerson@ nrc.gov. The cover letter should describe the nominee’s current involvement with patients’ rights advocacy and express the nominee’s interest in the position. Please ensure that the resume or curriculum vitae includes the following information, if applicable: education; certification; professional association membership and committee membership activities; and number of years, timeframe, and type of setting for patient advocacy. FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards; (301) 415–7408; Kellee.Jamerson@ nrc.gov. The ACMUI Nuclear Medicine Physician provides advice to the NRC staff on ideas associated with the regulation of diagnostic and therapeutic applications of byproduct material. This advice includes providing input on the NRC’s proposed rules and guidance documents; providing recommendations on the training and experience requirements for physicians specializing in diagnostic and therapeutic nuclear medicine; identifying medical events associated with these uses; evaluating non-routine medical uses of byproduct material; bringing key issues in the nuclear medicine community to the attention of the NRC staff; and other nuclear medicine issues as they relate to radiation safety and the NRC MedicalUse Policy Statement. The ACMUI Patients’ Rights Advocate provides advice to the NRC staff on patients’ issues associated with the regulation of medical applications of byproduct material. This advice includes ensuring patients’ rights are represented during the development and implementation of the NRC’s medical-use regulations. This individual is appointed based on his or her professional and personal experience with and/or knowledge about patient advocacy, as well as involvement and/ SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:16 Feb 19, 2019 Jkt 247001 or leadership with patient advocacy organizations. ACMUI members are selected based on their educational background, certification(s), work experience, involvement and/or leadership in professional society activities, and other information obtained in letters or during the selection process. Nominees should have the demonstrated ability to establish effective work relationships with peers and implement successful approaches to problem solving and conflict resolution. ACMUI members currently serve a four-year term and may be considered for reappointment to an additional term. The current ACMUI membership is comprised of the following professionals: (a) Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear medicine physicist; (d) therapy medical physicist; (e) radiation safety officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) patients’ rights advocate; (i) Food and Drug Administration representative; (j) Agreement State representative; (k) health care administrator; and (l) diagnostic radiologist. For additional information about membership on the ACMUI, visit the ACMUI Membership web page, https://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/ membership.html. Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to ACMUI business. Members are expected to attend semiannual meetings in Rockville, Maryland and to participate in teleconferences, as needed. Members who are not Federal employees are compensated for their service. In addition, members are reimbursed for travel (including per diem in lieu of subsistence) and are reimbursed secretarial and correspondence expenses. Full-time Federal employees are reimbursed for travel expenses only. Security Background Check: The selected nominee will undergo a thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest. Dated at Rockville, Maryland this 13th day of February, 2019. For the Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2019–02721 Filed 2–19–19; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 NUCLEAR REGULATORY COMMISSION [Docket No. 50–608; NRC–2019–0029] SHINE Medical Isotope Production Facility; Consideration of Approval of Transfer of License and Conforming Amendment Nuclear Regulatory Commission. ACTION: Application for indirect transfer of license; opportunity to comment, request a hearing, and petition for leave to intervene. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) received and is considering approval of an application filed by SHINE Medical Technologies, Inc. (SHINE) on December 11, 2018. The application seeks NRC approval of the indirect transfer of Construction Permit No. CPMIF–001 for the SHINE Medical Isotope Production Facility, currently held by SHINE. The indirect transfer will result from the establishment of a holding company, Illuminated Holdings, Inc. (Illuminated). The NRC is also considering amending Construction Permit No. CPMIF–001 for administrative purposes to reflect the proposed transfer. The application contains sensitive unclassified nonsafeguards information (SUNSI). DATES: Comments must be filed by March 22, 2019. A request for a hearing must be filed by March 12, 2019. Any potential party as defined in § 2.4 of title 10 of the Code of Federal Regulations (10 CFR), who believes access to SUNSI is necessary to respond to this notice must follow the instructions in Section VI of the SUPPLEMENTARY INFORMATION section of this notice. ADDRESSES: You may submit comments by any of the following methods (unless this document describes a different method for submitting comments on a specific subject): • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2019–0029. Address questions about Docket IDs in Regulations.gov to Krupskaya Castellon; telephone: 301–287–9221; email: Krupskaya.Castellon@nrc.gov. For technical questions contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Email comments to: Hearingdocket@nrc.gov. If you do not receive an automatic email reply confirming receipt, then contact us at 301–415–1677. • Fax comments to: Secretary, U.S. Nuclear Regulatory Commission at 301– 415–1101. SUMMARY: E:\FR\FM\20FEN1.SGM 20FEN1

Agencies

[Federal Register Volume 84, Number 34 (Wednesday, February 20, 2019)]
[Notices]
[Pages 5115-5116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02721]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Call for 
Nominations

AGENCY: Nuclear Regulatory Commission.

ACTION: Call for nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the Nuclear Medicine Physician position and the 
Patients' Rights Advocate position on the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI). Nuclear

[[Page 5116]]

Medicine Physician nominees should currently be practicing nuclear 
medicine in a clinical setting. Patients' Rights Advocate nominees 
should have professional or personal experience with or knowledge about 
patient advocacy. Also, involvement or leadership with patient advocacy 
organizations is preferred.

DATES: Nominations are due on or before April 22, 2019.

NOMINATION PROCESS: Submit an electronic copy of resume or curriculum 
vitae, along with a cover letter, to Ms. Kellee Jamerson, 
Kellee.Jamerson@nrc.gov. The cover letter should describe the nominee's 
current involvement with patients' rights advocacy and express the 
nominee's interest in the position. Please ensure that the resume or 
curriculum vitae includes the following information, if applicable: 
education; certification; professional association membership and 
committee membership activities; and number of years, timeframe, and 
type of setting for patient advocacy.

FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; (301) 415-7408; Kellee.Jamerson@nrc.gov.

SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Medicine Physician 
provides advice to the NRC staff on ideas associated with the 
regulation of diagnostic and therapeutic applications of byproduct 
material. This advice includes providing input on the NRC's proposed 
rules and guidance documents; providing recommendations on the training 
and experience requirements for physicians specializing in diagnostic 
and therapeutic nuclear medicine; identifying medical events associated 
with these uses; evaluating non-routine medical uses of byproduct 
material; bringing key issues in the nuclear medicine community to the 
attention of the NRC staff; and other nuclear medicine issues as they 
relate to radiation safety and the NRC Medical-Use Policy Statement.
    The ACMUI Patients' Rights Advocate provides advice to the NRC 
staff on patients' issues associated with the regulation of medical 
applications of byproduct material. This advice includes ensuring 
patients' rights are represented during the development and 
implementation of the NRC's medical-use regulations. This individual is 
appointed based on his or her professional and personal experience with 
and/or knowledge about patient advocacy, as well as involvement and/or 
leadership with patient advocacy organizations.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process. Nominees should have the 
demonstrated ability to establish effective work relationships with 
peers and implement successful approaches to problem solving and 
conflict resolution. ACMUI members currently serve a four-year term and 
may be considered for reappointment to an additional term. The current 
ACMUI membership is comprised of the following professionals: (a) 
Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear 
medicine physicist; (d) therapy medical physicist; (e) radiation safety 
officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) 
patients' rights advocate; (i) Food and Drug Administration 
representative; (j) Agreement State representative; (k) health care 
administrator; and (l) diagnostic radiologist. For additional 
information about membership on the ACMUI, visit the ACMUI Membership 
web page, https://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to ACMUI business. Members are expected to attend 
semi-annual meetings in Rockville, Maryland and to participate in 
teleconferences, as needed. Members who are not Federal employees are 
compensated for their service. In addition, members are reimbursed for 
travel (including per diem in lieu of subsistence) and are reimbursed 
secretarial and correspondence expenses. Full-time Federal employees 
are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland this 13th day of February, 2019.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-02721 Filed 2-19-19; 8:45 am]
 BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.